Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Quality-Of-Life Survey of Pancreatic Cancer Patients: A Comparison Between General Public and Physicians

Yuriko Sasahara
* ,
Yuki Takumoto
,
Kaname Watanabe
ORCID logo ,
Hiroyuki Takeda
ORCID logo ,
Kumiko Umemoto
,
Yu Sunakawa
ORCID logo ,
Naoki Suzuki
,
Takashi Yoshioka
,
Satoshi Kobayashi
,
Makoto Ueno
,
Sho Nakamura
ORCID logo ,
Manabu Akazawa
ORCID logo ,
Hiroto Narimatsu
* ORCID logo
Version 1 : Received: 20 April 2023 / Approved: 21 April 2023 / Online: 21 April 2023 (03:51:46 CEST)

How to cite: Sasahara, Y.; Takumoto, Y.; Watanabe, K.; Takeda, H.; Umemoto, K.; Sunakawa, Y.; Suzuki, N.; Yoshioka, T.; Kobayashi, S.; Ueno, M.; Nakamura, S.; Akazawa, M.; Narimatsu, H. Quality-Of-Life Survey of Pancreatic Cancer Patients: A Comparison Between General Public and Physicians. Preprints 2023, 2023040668. https://doi.org/10.20944/preprints202304.0668.v1 Sasahara, Y.; Takumoto, Y.; Watanabe, K.; Takeda, H.; Umemoto, K.; Sunakawa, Y.; Suzuki, N.; Yoshioka, T.; Kobayashi, S.; Ueno, M.; Nakamura, S.; Akazawa, M.; Narimatsu, H. Quality-Of-Life Survey of Pancreatic Cancer Patients: A Comparison Between General Public and Physicians. Preprints 2023, 2023040668. https://doi.org/10.20944/preprints202304.0668.v1

Abstract

Quality-of-life (QOL) is important for cancer patients with poor prognosis. However, QOL survey is difficult using patients. We created cancer scenarios and investigated QOL utility values among the general public using vignette-based methods. On the other hand, some scenarios may have been difficult for the general public to image and understand. Therefore, we conducted a QOL survey among physicians. This survey was conducted by interviewing physicians adminis-tering chemotherapy to patients for recurrent/metastatic pancreatic cancer. Responses were eval-uated using Composite Time Trade-Off (cTTO) and Visual Analog Scale (VAS) for 11 pancreatic cancer status scenarios to be evaluated (survey scenarios). Survey scenarios consisted of health state, type and Grade of adverse events. Health status was classified into two categories: Stable disease (SD) and Progressive disease (PD). Twenty responders answered in this survey, however two responses were excluded because of inconsistent responses. The stable disease had the highest QOL value for both assessment method. Whereas progression disease (PD) had the lowest QOL value. The physicians scored higher QOL values on VAS and cTTO than the general public in all survey scenarios. The QOL values obtained by physicians were consistent with the degree of sta-tus in any assessment scenarios.

Keywords

Quality-of-life; pancreatic cancer, physicians; VAS; cTTO; EQ-5D

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.